skip to content

School of the Biological Sciences

image of building

Named after its co-founder, Nobel Laureate Sir John Gurdon, the Gurdon Institute is a world-leading centre for research into the biology of development and how normal growth and maintenance go wrong in diseases such as cancer.

Based in the Old Addenbrookes Site in the centre of Cambridge, the Institute hosts more than 240 scientists in 16 research groups, working on projects ranging from breast cancer and brain development to liver regeneration and leukaemia. Many have made pioneering contributions to the fields of basic cell biology, cellular reprogramming, epigenetics and DNA repair.

Research conducted at the Institute has so far led to 13 spin-out companies (including KuDOS Pharmaceuticals, Abcam, CellCentric, Mission Therapeutics, Gen2 Neuro and Storm Therapeutics) and five candidate drugs. The Institute has a deep belief in its responsibility to contribute to society through their Public Engagement programme. In 2020 they were awarded the Silver Engage Watermark award for public engagement with an aim to inspire the next generation of scientists, positively impact the public perception of fundamental research and make public engagement part of the Institute’s research culture.

Learn more about the Gurdon Institute.

 

 

Milner Therapeutics Institute

Bringing discoveries to life

The Milner Therapeutics Institute encompasses both a research institute and a global outreach programme, which aims to transform pioneering science into therapies. Based in the Jeffrey Cheah Biomedical Centre on the Cambridge Biomedical Campus, they provide a unique setting where pharma, biotech, start-ups and academics work together in a common space, creating a research environment that breaks down barriers between these sectors.

The Milner Therapeutics Institute is home to academic research groups, the joint AstraZeneca-Cancer Research UK Functional Genomics Centre, the healthcare accelerator Start Codon and a bio-incubator space. The institute’s outreach programme brings together over 80 affiliated organisations, including global academic institutions, industry partners and investors.

Learn more about the Milner Therapeutics Institute.

Director:

Professor Ben Simons


Institute Administration and Operations Manager:

Vacant